Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy.

Marvell Technology (MRVL) projected fiscal 2028 revenue of $20B and fiscal 2031 revenue between $70B-$90B, up from $8.2B in fiscal 2026. Management cited market growth and increased long-term targets. Shares rose to around $290, trading at 43x expected fiscal 2028 earnings. The company's operating margin is expected to reach 38%-40% by fiscal 2028.

Original reporting
Published Oct 7, 2026, 8:03 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 7, 2026, 8:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Marvell Now Sees as Much as $90 Billion in Annual Sales by Fiscal 2031. Here's Why It's a Chip Stock to Buy. — source image
Decision brief

The 30-second read

$MRVLBullishMed
01

Why it matters

The new guidance could drive further buying pressure, but valuation concerns may temper the rally.

02

Market read

First report of substantially higher long‑term revenue targets for a major chip maker, likely influencing sector sentiment.

03

What to watch

Execution risk on custom chip programs and potential margin pressure from higher R&D spend.

Relevance 8/10Novelty 8/10Timing: today

Background

Marvell's prior quarterly results and guidance were released on Aug 27 2026; this article provides the first update on its long‑term targets.

Company-level read

Ticker impact

$MRVLBullishMedium confidence
Context

Marvell announced new long‑term revenue guidance of $70‑90 bn for fiscal 2031, up from prior guidance.

Expected impact

potential upside as the market prices in the higher growth outlook

Evidence & confidence

Guidance is materially higher than previous targets and the stock already rallied on the news, indicating investor optimism.

Market effects

Sets a higher growth benchmark for the semiconductor and data‑center chip sector.

U.S. tech equities may see modest lift as investors reassess long‑term demand.

Highlights the expanding AI‑driven chip market worldwide.

Counterpoint

The valuation may already be stretched; the guidance could be overly optimistic if AI demand slows.

Key entities

  • Marvell Technology

    U.S. semiconductor firm (NASDAQ:MRVL).

Related articles

$AVGOMed

Broadcom Plunges 11% as Google Reportedly Shifts TPU Orders to MediaTek, Overshadowing Goldman’s $460 Target; Marvell Sinks 10%

Broadcom (AVGO) fell 11% after reports that Google (GOOGL) may shift some TPU orders to MediaTek, raising concerns about customer concentration. Analyst Ming-Chi Kuo estimated a 20% reduction in Google's 2027 TPU orders for Broadcom. Goldman Sachs lowered its price target to $460 but maintained a Buy rating. Marvell (MRVL) also dropped 10%, while NVIDIA (NVDA) fell 7%. Broadcom's AI revenue grew 221% YoY in Q3 FY2026, and it expects $21.7B in AI revenue for Q4 FY2026.

$MRVLHighAI 9/10

Marvell and Lumentum deal: good, real, and ugly scenarios

Marvell Technology (MRVL) and Lumentum Holdings (LITE) are discussing a potential merger. MRVL trades at $126.38, down 8.73%, with a market cap of $111.59B. LITE trades at $482.95, down 9.75%, with a market cap of $44.10B. The deal aims to combine MRVL's platform ambition with LITE's optical capacity, with projected annual synergies of over $1B. The transaction is all-stock, with LITE shareholders receiving 4.5 MRVL shares per share.

$MRVLMed

Why is Marvell Technology stock sliding today?

Marvell Technology (MRVL) fell 8.3% to $126.98, extending a decline tied to its proposed all-stock acquisition of Lumentum Holdings. The deal values Lumentum at about $115B and would leave Marvell shareholders with ~67%. Stifel cut its MRVL target to $280 from $370; Oppenheimer kept a $425 Buy.

$MRVLMed

Who Owns Marvell Technology Stock (MRVL) Ahead of Q3 Earnings?

Marvell Technology (MRVL) is set to report Q3 earnings on December 1. Shares have fallen 42% in a month but are up 63% year-to-date. ETFs own 32.91% of MRVL, with BlackRock and iShares as top holders. Analysts expect EPS of $1.10 and revenue of $3.15B. Bank of America downgraded MRVL to Hold, citing acquisition concerns, while Oppenheimer maintained a Buy rating.